Sharon Martin
Family Medicine · Orbisonia, PANPI 1891884375
Payments from drug & device makers
Across 263 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- GSK$467
- Lilly USA, LLC$439
- Boehringer Ingelheim$336
- AstraZeneca$309
- AbbVie$231
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,092100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 78 | $1,198 |
| GSK | 34 | $467 |
| Lilly USA, LLC | 30 | $439 |
| Boehringer Ingelheim | 24 | $336 |
| AstraZeneca | 17 | $309 |
| AbbVie | 10 | $231 |
| Daiichi Sankyo Inc. | 10 | $215 |
| Sanofi-aventis U.S. LLC | 14 | $179 |
| Abbott | 5 | $105 |
| Novartis | 6 | $90 |
| Exact Sciences | 4 | $79 |
| Johnson & Johnson | 5 | $78 |
| Astellas Pharma US Inc | 5 | $78 |
| Pfizer | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $39 |
| Merck | 3 | $36 |
| Amarin Pharma, Inc. | 2 | $24 |
| Verona Pharma, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Bayer | 1 | $13 |
| Philips North America LLC | 1 | $13 |
| Bardy Diagnostics, Inc. | 1 | $6 |
How this compares
$4,092 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 229 | $191,203 |
| EliquisApixaban | 140 | $98,932 |
| OzempicSemaglutide | 71 | $72,957 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 58 | $37,547 |
| MounjaroTirzepatide | 31 | $35,176 |
| TrulicityDulaglutide | 33 | $32,398 |
| XareltoRivaroxaban | 24 | $20,750 |
| MyrbetriqMirabegron | 32 | $17,051 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $15,244 |
| TradjentaLinagliptin | 18 | $13,743 |
| FarxigaDapagliflozin Propanediol | 16 | $9,882 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $8,431 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $7,134 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 22 | $7,062 |
| BrilintaTicagrelor | 12 | $6,478 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat | $336 | $210,459259 claims |
| PfizerEliquis | $42 | $98,932140 claims |
| Novo NordiskOzempic | $1,198 | $72,95771 claims |
| Lilly USA, LLCMounjaro, Trulicity | $439 | $67,57464 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $467 | $53,11290 claims |
| Johnson & JohnsonXarelto | $78 | $20,75024 claims |
| Astellas Pharma US IncMyrbetriq | $78 | $17,05132 claims |
| AstraZenecaFarxiga, Brilinta | $309 | $16,36028 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Orbisonia
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.